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THE development of procedures to isolate large num-bers of purified human pancreatic islet cells has made 
it possible to initiate a new phase of clinical trials in 
pancreatic islet transplantation for treatment of type 1 
diabetes. 1-3 Although nonspecific immunosuppressive 
agents have been instrumental in controlling alloreactivity 
to transplanted islet cells. rejection still occurs and is a 
major limitation to islet transplantation.4 The induction of 
donor-specific transplantation across a species barrier. 
using bone marrow stem cells to produce chimerism. has 
been suggested as a potential approach to prevent rejection 
of transplanted cells and overcome the shortage of avail-
able grafts. We recently reported that acceptance of donor-
specific islet cell xenografts was achieved in fully xenoge-
neic chimeras (WF rat to 810 mouse) when WF rat (RtlAU ) 
was the xenogeneic donor. To exclude a strain-specific 
effect. we have now evaluated whether similar tolerance 
would be present when F344 rat (RtiA 1) was used as the 
xenogeneic donor. We report here that long-term accep-
tance and function of donor-specific (F344 rat) xenogeneic 
pancreatic islet grafts could be achieved in fully xenoge-
neic chimeras (810 mouse + F344 rat to 810 mouse). 
MATERIALS AND METHODS 
Fully xenogeneic chimeras were prepared as previously de-
scribed.5 Chimeras were made diabetic by a single intravenous 
injection of streptozotocin (165 mglkg). Rat pancreatic islets were 
obtained and transplanted as previously reported.6 
RESULTS AND DISCUSSION 
After placement of either donor-specific F344 rat or third-
party WF islet cell xenografts, normoglycemia occurred. 
indicating technical success. The survival of donor-specific 
F344 rat pancreatic islet xenografts was significantly pro-
longed (mean survival time [MST] 180 days; Fig 1). In 
contrast, major histocompatibility complex-disparate 
third-party WF rat islets were rapidly rejected. as evi-
denced by return of hyperglycemia (MST. 8 days). The 
donor-specific F344 grafts were functional to maintain the 
normoglycemic state in chimeras. This study demonstrates 
that long-term survival and function of donor-specific 
pancreatic islet xenografts could be obtained in fully 
xenogeneic chimeras and was not limited to a single strain 
as the xenogeneic donor. 
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Fig 1. Kinetics of blood glucose determination after streptozo-
tocin. after placement of a donor-specific islet cell xenograft in fully 
xenogeneic chimera. 
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